Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials ; volume:11 ; number:1 ; day:5 ; month:11 ; year:2023 ; pages:35-50 ; date:2.2024
Rheumatology and therapy ; 11, Heft 1 (5.11.2023), 35-50, 2.2024
- Urheber
-
Citera, Gustavo
Jain, Rakesh
Irazoque, Fedra
Madariaga, Hugo
Gruben, David
Wang, Lisy
Stockert, Lori
Santana, Karina
Ebrahim, Abbas
Ponce de Leon, Dario
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-023-00612-7
- URN
-
urn:nbn:de:101:1-2024033111324635406188
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
03.04.2025, 00:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Citera, Gustavo
- Jain, Rakesh
- Irazoque, Fedra
- Madariaga, Hugo
- Gruben, David
- Wang, Lisy
- Stockert, Lori
- Santana, Karina
- Ebrahim, Abbas
- Ponce de Leon, Dario
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
Oral health-related quality of life, probable depression and probable anxiety: evidence from a representative survey in Germany
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Es probable
Very probable
Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
Oral health-related quality of life, probable depression and probable anxiety: evidence from a representative survey in Germany
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Es probable
Very probable
Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
Oral health-related quality of life, probable depression and probable anxiety: evidence from a representative survey in Germany
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Es probable